Fortress Biotech, Inc. - 30 May 2025 SCHEDULE 13D/A Report for Checkpoint Therapeutics, Inc. Common Stock, $0.0001 Par Value (CKPT)

Filing Manager: Fortress Biotech, Inc.
Reporting Manager: Fortress Biotech, Inc.
Security: Checkpoint Therapeutics, Inc. Common Stock, $0.0001 Par Value
Symbol: CKPT
Disclosed Ownership: 0 shares
Ownership: 0%
Form type: SCHEDULE 13D/A
Filing time: 03 Jun 2025, 18:46:56 UTC
Date of event: 30 May 2025
Previous filing: 11 Mar 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Fortress Biotech, Inc.	0%	0	0	0	/s/ Lindsay A. Rosenwald	Lindsay A. Rosenwald, M.D. / Chairman, President and Chief Executive Officer	0001429260